Susan Nmn Ungar

Array ( [id] => 6796981 [patent_doc_number] => 20030175855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'HUMAN SDF-5 PROTEIN AND COMPOSITIONS' [patent_app_type] => new [patent_app_number] => 08/949904 [patent_app_country] => US [patent_app_date] => 1997-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19167 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175855.pdf [firstpage_image] =>[orig_patent_app_number] => 08949904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3931546 [patent_doc_number] => 05939273 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-17 [patent_title] => 'Anti .alpha.-gal screening technique' [patent_app_type] => 1 [patent_app_number] => 8/943040 [patent_app_country] => US [patent_app_date] => 1997-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5868 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/939/05939273.pdf [firstpage_image] =>[orig_patent_app_number] => 943040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3994948 [patent_doc_number] => 05922548 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-13 [patent_title] => 'Anti .alpha.-gal screening technique' [patent_app_type] => 1 [patent_app_number] => 8/942807 [patent_app_country] => US [patent_app_date] => 1997-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5874 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 234 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/922/05922548.pdf [firstpage_image] =>[orig_patent_app_number] => 942807 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3999346 [patent_doc_number] => 05922836 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-13 [patent_title] => 'Mammaglobin antigens' [patent_app_type] => 1 [patent_app_number] => 8/933149 [patent_app_country] => US [patent_app_date] => 1997-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 13139 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/922/05922836.pdf [firstpage_image] =>[orig_patent_app_number] => 933149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3947122 [patent_doc_number] => 05955287 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Method of determining level of biological substances elevated in the presence of cancer and other neoplasms' [patent_app_type] => 1 [patent_app_number] => 8/928154 [patent_app_country] => US [patent_app_date] => 1997-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 23 [patent_no_of_words] => 11194 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955287.pdf [firstpage_image] =>[orig_patent_app_number] => 928154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4021464 [patent_doc_number] => 05925543 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-20 [patent_title] => 'Isolated polynucleotide sequence encoding NADH dehydrogenase B17 subunit' [patent_app_type] => 1 [patent_app_number] => 8/928926 [patent_app_country] => US [patent_app_date] => 1997-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19838 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/925/05925543.pdf [firstpage_image] =>[orig_patent_app_number] => 928926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3946414 [patent_doc_number] => 05990275 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-23 [patent_title] => 'Linker and linked fusion polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/926789 [patent_app_country] => US [patent_app_date] => 1997-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 16214 [patent_no_of_claims] => 102 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/990/05990275.pdf [firstpage_image] =>[orig_patent_app_number] => 926789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6345108 [patent_doc_number] => 20020035244 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-21 [patent_title] => 'REAGENTS AND METHODS USEFUL FOR DETECTING DISEASES OF THE PROSTATE' [patent_app_type] => new [patent_app_number] => 08/926626 [patent_app_country] => US [patent_app_date] => 1997-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 34823 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20020035244.pdf [firstpage_image] =>[orig_patent_app_number] => 08926626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4413727 [patent_doc_number] => 06193963 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-27 [patent_title] => 'Method of treating tumor-bearing patients with human plasma hyaluronidase' [patent_app_type] => 1 [patent_app_number] => 8/916935 [patent_app_country] => US [patent_app_date] => 1997-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 13 [patent_no_of_words] => 22888 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/193/06193963.pdf [firstpage_image] =>[orig_patent_app_number] => 916935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1416190 [patent_doc_number] => 06514685 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-04 [patent_title] => 'Detection of cancer using antibodies to the alphafeto protein receptor' [patent_app_type] => B1 [patent_app_number] => 08/920654 [patent_app_country] => US [patent_app_date] => 1997-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10417 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 165 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/514/06514685.pdf [firstpage_image] =>[orig_patent_app_number] => 08920654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5800909 [patent_doc_number] => 20020009468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-24 [patent_title] => 'COMPOSITIONS AND METHODS FOR CANCER PROPHYLAXIS AND/OR TREATMENT' [patent_app_type] => new [patent_app_number] => 08/929464 [patent_app_country] => US [patent_app_date] => 1997-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 16117 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20020009468.pdf [firstpage_image] =>[orig_patent_app_number] => 08929464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1579307 [patent_doc_number] => 06448376 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-10 [patent_title] => 'Transcription factor-E2F-5' [patent_app_type] => B1 [patent_app_number] => 08/894139 [patent_app_country] => US [patent_app_date] => 1997-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 20 [patent_no_of_words] => 20795 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/448/06448376.pdf [firstpage_image] =>[orig_patent_app_number] => 08894139 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3905546 [patent_doc_number] => 06001359 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-14 [patent_title] => 'Diagnosis of colon carcinoma using monoclonal antibodies to human influx peptide transporter' [patent_app_type] => 1 [patent_app_number] => 8/909502 [patent_app_country] => US [patent_app_date] => 1997-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9317 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/001/06001359.pdf [firstpage_image] =>[orig_patent_app_number] => 909502 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6276028 [patent_doc_number] => 20020106688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-08 [patent_title] => 'IDENTIFICATION OF GENE SEQUENCES AND GENE PRODUCTS AND THEIR SPECIFIC FUNCTION AND RELATIONSHIP TO PATHOLOGIES IN A MAMMAL' [patent_app_type] => new [patent_app_number] => 08/906487 [patent_app_country] => US [patent_app_date] => 1997-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31054 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20020106688.pdf [firstpage_image] =>[orig_patent_app_number] => 08906487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4059842 [patent_doc_number] => 05864015 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-26 [patent_title] => 'Hodgkin\'s disease associated molecules' [patent_app_type] => 1 [patent_app_number] => 8/905445 [patent_app_country] => US [patent_app_date] => 1997-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8641 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/864/05864015.pdf [firstpage_image] =>[orig_patent_app_number] => 905445 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3939592 [patent_doc_number] => 05989830 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-23 [patent_title] => 'Bifunctional or bivalent antibody fragment analogue' [patent_app_type] => 1 [patent_app_number] => 8/860174 [patent_app_country] => US [patent_app_date] => 1997-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 50 [patent_no_of_words] => 21252 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/989/05989830.pdf [firstpage_image] =>[orig_patent_app_number] => 860174 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4320297 [patent_doc_number] => 06328966 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => 'Transferrin compositions to alleviate the side effects of cytotoxic drugs' [patent_app_type] => 1 [patent_app_number] => 8/899140 [patent_app_country] => US [patent_app_date] => 1997-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 13 [patent_no_of_words] => 2703 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/328/06328966.pdf [firstpage_image] =>[orig_patent_app_number] => 899140 [rel_patent_id] =>[rel_patent_doc_number] =>)